nitrates has been researched along with Glomerulonephritis in 11 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis." | 7.72 | NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis. ( Daig, U; Krämer, S; Liefeldt, L; Martini, S; Neumayer, HH; Peters, H; Rückert, M; Schäper, F, 2003) |
| " Here we assess the therapeutic effect of L-arginine supplementation, which has been shown to reduce fibrosis in a number of hypertensive models, given alone or in combination with low protein diet and started 24 hours after disease induction." | 7.70 | Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. ( Border, WA; Noble, NA; Peters, H, 2000) |
| "NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis." | 3.72 | NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis. ( Daig, U; Krämer, S; Liefeldt, L; Martini, S; Neumayer, HH; Peters, H; Rückert, M; Schäper, F, 2003) |
| "To explore the effects of ligustrazine on proteinuria, urinary TxB2 (metabolism of thromboxane A2, TxA2) and 6-keto-PGF1alpha (metabolism of prostacyclines I2, PG I2), glomerular inducible nitric oxide(NO) synthase (iNOS) mRNA, urinary NO3-/NO2- (decomposing products of NO) and pathological changes in rats with passive Heymann nephritis (PHN)." | 3.72 | Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis. ( Dong, H; Tang, R; Tong, J; Wang, Y; Xu, J, 2004) |
| " Here we assess the therapeutic effect of L-arginine supplementation, which has been shown to reduce fibrosis in a number of hypertensive models, given alone or in combination with low protein diet and started 24 hours after disease induction." | 3.70 | Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. ( Border, WA; Noble, NA; Peters, H, 2000) |
| " Oral administration of NG-monomethyl-L-arginine, a nitric oxide synthase inhibitor, prevented the development of glomerulonephritis and reduced the intensity of inflammatory arthritis in MRL-lpr/lpr mice." | 3.69 | The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally admi ( Gilkeson, GS; Granger, DL; Mason, SN; Misukonis, MA; Pippen, AM; Pisetsky, DS; Ruiz, P; Seldin, MF; Weinberg, JB; Wood, ER, 1994) |
| "Captopril treatment protected rats receiving L-NAME and none of the captopril-treated rats died." | 1.30 | Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis. ( Eriksson, A; Fyhrquist, F; Holthöfer, H; Miettinen, A; Tikkanen, I; Tikkanen, T; Törnroth, T; Uhlenius, N, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wagner, L | 1 |
| Riggleman, A | 1 |
| Erdely, A | 1 |
| Couser, W | 1 |
| Baylis, C | 1 |
| Ogawa, D | 1 |
| Shikata, K | 1 |
| Matsuda, M | 1 |
| Okada, S | 1 |
| Usui, H | 1 |
| Wada, J | 1 |
| Taniguchi, N | 1 |
| Makino, H | 1 |
| Peters, H | 2 |
| Daig, U | 1 |
| Martini, S | 1 |
| Rückert, M | 1 |
| Schäper, F | 1 |
| Liefeldt, L | 1 |
| Krämer, S | 1 |
| Neumayer, HH | 1 |
| Wang, Y | 1 |
| Tong, J | 1 |
| Tang, R | 1 |
| Dong, H | 1 |
| Xu, J | 1 |
| Weinberg, JB | 2 |
| Granger, DL | 1 |
| Pisetsky, DS | 1 |
| Seldin, MF | 1 |
| Misukonis, MA | 1 |
| Mason, SN | 1 |
| Pippen, AM | 1 |
| Ruiz, P | 1 |
| Wood, ER | 1 |
| Gilkeson, GS | 2 |
| Lianos, EA | 1 |
| Guglielmi, K | 1 |
| Sharma, M | 1 |
| Uhlenius, N | 1 |
| Tikkanen, T | 1 |
| Miettinen, A | 1 |
| Holthöfer, H | 1 |
| Törnroth, T | 1 |
| Eriksson, A | 1 |
| Fyhrquist, F | 1 |
| Tikkanen, I | 1 |
| Kakoki, M | 1 |
| Matsumoto, A | 1 |
| Nagata, D | 1 |
| Kobayakawa, N | 1 |
| Kimura, K | 1 |
| Momomura, S | 1 |
| Hirata, Y | 1 |
| Border, WA | 1 |
| Noble, NA | 1 |
| Keng, T | 1 |
| Privalle, CT | 1 |
| Sever, R | 1 |
| Cook, T | 1 |
| Cattell, V | 1 |
11 other studies available for nitrates and Glomerulonephritis
| Article | Year |
|---|---|
Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis.
Topics: Animals; Antibodies; Arginine; Autoantibodies; Blood Urea Nitrogen; Creatinine; Glomerulonephritis; | 2002 |
Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats.
Topics: Amidines; Animals; Disease Progression; Enzyme Inhibitors; Glomerulonephritis; Heterocyclic Compound | 2002 |
NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
Topics: Animals; Arginine; Blood Pressure; Body Weight; Enzyme Inhibitors; Fibronectins; Fibrosis; Gene Expr | 2003 |
Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Female; Fluorescent Antibody Technique, Direct; | 2004 |
The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally admi
Topics: Administration, Oral; Amino Acid Oxidoreductases; Animals; Arginine; Arthritis; Autoimmune Diseases; | 1994 |
Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury.
Topics: Animals; Base Sequence; Basement Membrane; Cyclooxygenase Inhibitors; Disease Models, Animal; DNA Pr | 1998 |
Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pre | 1999 |
Analysis of nitric oxide in the exhaled air of patients with chronic glomerulonephritis.
Topics: Administration, Oral; Analysis of Variance; Anti-Inflammatory Agents; Case-Control Studies; Chronic | 1999 |
Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis.
Topics: Animals; Arginine; Culture Techniques; Dietary Proteins; Fibrosis; Glomerulonephritis; Kidney; Kidne | 2000 |
Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice.
Topics: Animals; Arthritis; Autoimmune Diseases; Catalase; Cattle; DNA Damage; Glomerulonephritis; Immunoblo | 2000 |
Urinary excretion of nitrite and nitrate in experimental glomerulonephritis reflects systemic immune activation and not glomerular synthesis.
Topics: Animals; Glomerulonephritis; Kidney Glomerulus; Lipopolysaccharides; Macrophages; Male; Nitrates; Ni | 1992 |